Examining patient access to investigational drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. October 3, 2017

Examining patient access to investigational drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. October 3, 2017.

Author/creator	United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Format	Electronic and Book
Publication Info	Washington : U.S. Government Publishing Office, 2018.
Description	1 online resource (iv, 235 pages) : photographs
Supplemental Content	https://purl.fdlp.gov/GPO/gpo113883
Subject(s)	United States. Food and Drug Administration. Clinical trials--United States. Clinical trials--Moral and ethical aspects --United States. Drugs--United States --Testing. Drugs--Testing --Moral and ethical aspects --United States.

General note	"Serial No. 115-60."
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Source of description	Description based on online resource, PDF version; title from title page (govinfo, viewed Dec. 27, 2018).
Issued in other form	Microfiche version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining patient access to investigational drugs
Issued in other form	Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Examining patient access to investigational drugs
Genre/form	Legislative hearings.
Technical rpt number	Serial no. 115-60 (United States. Congress. House. Committee on Energy and Commerce)
GPO item number	1019-C-01 (online)
Govt. docs number	Y 4.C 73/8:115-60

Library	Location	Call Number	Status	Item Actions
Joyner	Electronic Resources	Access Content Online	✔ Available